Skip to main content
. Author manuscript; available in PMC: 2022 Aug 18.
Published in final edited form as: Cancer Res Commun. 2022 Feb 11;2(2):90–98. doi: 10.1158/2767-9764.CRC-21-0142

Table 3.

mSEPT9 status by demographics of EOCRC cases and healthy controls.

Variable Healthy controls <50 years (N=48) Healthy controls ≥50 years (N=39) EOCRC (N=27)

Age (n, %)
26–29 0/1 (0.0) - 1/1 (100.0)
30–34 0/1 (0.0) - 1/1 (100.0)
35–39 0/4 (0.0) - 3/3 (100.0)
40–44 1/20 (5.0) - 10/11 (90.9)
45–49 1/23 (4.3) - 9/11 (81.8)
50–54 - 3/17 (17.6) -
55–59 - 1/7 (14.3) -
60–64 - 1/8 (12.5) -
65–69 - 1/5 (20.0) -
70+ - 0/2 (0.0) -

Race (n, %)
White 1/9 (11.1) 4/21 (19.0) 19/22 (86.3)
Black 1/23 (4.3) 0/5 (0.0) 2/2 (100.0)
Hispanic 0/15 (0.0) 2/7 (28.6) 0/0 (0.0)
Asian 0/1 (0.0) 0/5 (0.0) 1/1 (100.0)
Unknown 0/0 (0.0) 0/1 (0/0) 2/2 (100.0)

Sex (n, %)
Female 0/17 (0.0) 2/14 (14.3) 11/11 (100.0)
Male 2/21 (9.5) 4/25 (16.0) 13/16 (81.3)

Cancer site (n, %)
Colon - - 3/3 (100.0)
Rectum - - 15/18 (83.3)
Unspecified colorectal site - - 6/6 (100.0)

Stage (n, %)
I - - 4/4 (100.0)
II - - 1/1 (100.0)
III - - 5/5 (100.0)
IV - - 12/12 (100.0)
Unknown - - 2/5 (40.0)

Tumor grade (n, %)
Low, low/intermediate - - 10/11 (90.9)
Intermediate - - 5/6 (83.3)
High - - 6/7 (85.7)
Unknown - - 3/3 (100.0)

Survival status, overall (n, %)
Alive - - 18/21 (85.7)
Deceased - - 6/6 (100.0)

Family history of cancer (n, %)
Yes - - 19/21 (90.5)
No - - 4/5 (80.0)
Unknown - - 1/1 (100.0)

Family history of CRC (n, %)
Yes - - 8/9 (88.9)
No - - 15/17 (88.2)
Unknown - - 1/1 (100.0)

History of IBD or chronic inflammation (n, %)
Yes - - 5/5 (100.0)
No - - 19/22 (86.4)